top of page
The future of HIT diagnosis

VISION: Retham Technologies™ seeks to revolutionize the diagnosis and management of Heparin induced thrombocytopenia (HIT).

MISSION: Retham Technologies™ will develop a technically-simple HIT IVD test, HITDx™, for accurate and timely HIT diagnosis.  HITDx™ is expected to decreases morbidity, save lives and lower the cost of care for HIT-suspected patients.


Retham Technologies™ LLC was established in 2017 to translate recent discoveries into a life-saving in vitro diagnostic (IVD) assay that provides earlier and more accurate in-hospital diagnosis of Heparin-induced Thrombocytopenia (HIT).

HIT is a serious adverse reaction to the blood thinner heparin. It is characterized by a drop in platelet count (thrombocytopenia) and in ~1/3rd of cases, causes blood clotting (thrombosis) that can result in life-and-limb threatening consequences such as amputation, stroke and death.  The diagnosis of HIT is challenging.  A family of easy-to-run tests called PF4 ELISAs is performed in the hospital laboratory but have high false positive rates, i.e. many patients positive for antibodies to PF4:polyanion complexes do not have clinical HIT.  A second test, the Serotonin release assay (SRA), is considered the “gold-standard” test for HIT; but, it is performed only at a handful of laboratories nationally on a small fraction of suspected cases due to technical complexity, cost and turnaround time concerns. Thus, >90% of HIT suspected patients are currently managed using PF4 ELISAs, and thousands of patients receive costly non-heparin anticoagulant therapy due to “false positive” diagnoses.  These alternative anticoagulants have a worse bleeding risk profile relative to heparin often resulting in severe or fatal hemorrhage.


Retham Technologies™ is developing HITDx™, an IVD assay for early and accurate near-patient HIT diagnosis that is expected to facilitate timely and appropriate therapy thereby leading to better outcomes.


Retham Technologies LLC
1225 Discovery Pkwy

Wauwatosa, WI 53226


Success! Message received.

bottom of page